{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:53:59Z","timestamp":1792637639662,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"crossref","award":["TLGM-NDD"],"award-info":[{"award-number":["TLGM-NDD"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"crossref","award":["TLGM-NDD"],"award-info":[{"award-number":["TLGM-NDD"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12035-019-1579-1","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:02:22Z","timestamp":1554163342000},"page":"6873-6882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impaired Remyelination in a Mouse Model of Huntington Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Roy Tang Yi","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Ferrari Bardile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Lin","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Amirah Binte Mohammad","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel A.","family":"Kreidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang Juin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-0976","authenticated-orcid":false,"given":"Mahmoud A.","family":"Pouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"1579_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","volume":"30","author":"K-A Nave","year":"2014","unstructured":"Nave K-A, Werner HB (2014) Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 30:503\u2013533. \n                    https:\/\/doi.org\/10.1146\/annurev-cellbio-100913-013101","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1579_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1098\/rstb.2006.2013","volume":"363","author":"N Kessaris","year":"2008","unstructured":"Kessaris N, Pringle N, Richardson WD (2008) Specification of CNS glia from neural stem cells in the embryonic neuroepithelium. Philosophical Transactions of the Royal Society B: Biological Sciences 363:71\u201385. \n                    https:\/\/doi.org\/10.1098\/rstb.2006.2013","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"key":"1579_CR3","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.2220","volume":"11","author":"LE Rivers","year":"2008","unstructured":"Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, Kessaris N, Richardson WD (2008) PDGFRA\/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 11:1392\u20131401. \n                    https:\/\/doi.org\/10.1038\/nn.2220","journal-title":"Nat Neurosci"},{"key":"1579_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2013.10.018","volume":"276","author":"S Wang","year":"2014","unstructured":"Wang S, Young KM (2014) White matter plasticity in adulthood. Neuroscience 276:148\u2013160. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2013.10.018","journal-title":"Neuroscience"},{"key":"1579_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-neuro-080317-061853","volume":"41","author":"M Monje","year":"2018","unstructured":"Monje M (2018) Myelin plasticity and nervous system function. Annu Rev Neurosci 41:61\u201376. \n                    https:\/\/doi.org\/10.1146\/annurev-neuro-080317-061853","journal-title":"Annu Rev Neurosci"},{"key":"1579_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJM Franklin","year":"2008","unstructured":"Franklin RJM, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839\u2013855. \n                    https:\/\/doi.org\/10.1038\/nrn2480","journal-title":"Nat Rev Neurosci"},{"key":"1579_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.1190927","volume":"330","author":"B Emery","year":"2010","unstructured":"Emery B (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330:779\u2013782. \n                    https:\/\/doi.org\/10.1126\/science.1190927","journal-title":"Science"},{"key":"1579_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1","journal-title":"Lancet"},{"key":"1579_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"1579_CR10","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85:5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1579_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL et al (2009) Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791\u2013801. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(09)70170-X","journal-title":"Lancet Neurol"},{"key":"1579_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","volume":"82","author":"JS Paulsen","year":"2010","unstructured":"Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK et al (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.brainresbull.2010.04.003","journal-title":"Brain Res Bull"},{"key":"1579_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","volume":"74","author":"GR Poudel","year":"2015","unstructured":"Poudel GR, Stout JC, Dom\u00ednguez DJF et al (2015) Longitudinal change in white matter microstructure in Huntington\u2019s disease: the IMAGE-HD study. Neurobiol Dis 74:406\u2013412. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2014.12.009","journal-title":"Neurobiol Dis"},{"key":"1579_CR14","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3389\/fnins.2016.00197","volume":"10","author":"OR Phillips","year":"2016","unstructured":"Phillips OR, Joshi SH, Squitieri F, Sanchez-Castaneda C, Narr K, Shattuck DW, Caltagirone C, Sabatini U et al (2016) Major superficial white matter abnormalities in Huntington\u2019s disease. Front Neurosci 10:1655\u20131613. \n                    https:\/\/doi.org\/10.3389\/fnins.2016.00197","journal-title":"Front Neurosci"},{"key":"1579_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.nicl.2018.01.029","volume":"20","author":"HD Rosas","year":"2018","unstructured":"Rosas HD, Wilkens P, Salat DH, Mercaldo ND, Vangel M, Yendiki AY, Hersch SM (2018) Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease. Neuroimage (Amst) 20:236\u2013242. \n                    https:\/\/doi.org\/10.1016\/j.nicl.2018.01.029","journal-title":"Neuroimage (Amst)"},{"key":"1579_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cortex.2013.11.009","volume":"52","author":"MJU Novak","year":"2014","unstructured":"Novak MJU, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, Tabrizi SJ (2014) White matter integrity in premanifest and early Huntington\u2019s disease is related to caudate loss and disease progression. Cortex 52:98\u2013112. \n                    https:\/\/doi.org\/10.1016\/j.cortex.2013.11.009","journal-title":"Cortex"},{"key":"1579_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","volume":"43","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Lerch JP, Franciosi S, Spreeuw A, Bissada N, Henkelman RM, Hayden MR (2011) Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease. Neurobiol Dis 43:257\u2013265. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.03.018","journal-title":"Neurobiol Dis"},{"key":"1579_CR18","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","volume":"31","author":"Z Xiang","year":"2011","unstructured":"Xiang Z, Valenza M, Cui L, Leoni V, Jeong HK, Brilli E, Zhang J, Peng Q et al (2011) Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington\u2019s disease. J Neurosci 31:9544\u20139553. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1291-11.2011","journal-title":"J Neurosci"},{"key":"1579_CR19","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","volume":"24","author":"J Jin","year":"2015","unstructured":"Jin J, Peng Q, Hou Z, Jiang M, Wang X, Langseth AJ, Tao M, Barker PB et al (2015) Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 24:2508\u20132527. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv016","journal-title":"Hum Mol Genet"},{"key":"1579_CR20","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1093\/hmg\/ddw122","volume":"25","author":"RTY Teo","year":"2016","unstructured":"Teo RTY, Hong X, Yu-Taeger L, Huang Y, Tan LJ, Xie Y, To XV, Guo L et al (2016) Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease. Hum Mol Genet 25:2621\u20132632. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddw122","journal-title":"Hum Mol Genet"},{"key":"1579_CR21","doi-asserted-by":"publisher","first-page":"31652","DOI":"10.1038\/srep31652","volume":"6","author":"M Garcia-Miralles","year":"2016","unstructured":"Garcia-Miralles M, Hong X, Tan LJ, Caron NS, Huang Y, To XV, Lin RY, Franciosi S et al (2016) Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease. Sci Rep 6:31652. \n                    https:\/\/doi.org\/10.1038\/srep31652","journal-title":"Sci Rep"},{"key":"1579_CR22","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s12035-018-1393-1","volume":"130","author":"M Garcia-Miralles","year":"2018","unstructured":"Garcia-Miralles M, Yusof NABM, Tan JY, Radulescu CI, Sidik H, Tan LJ, Belinson H, Zach N et al (2018) Laquinimod treatment improves myelination deficits at the transcriptional and ultrastructural levels in the YAC128 mouse model of Huntington disease. Mol Neurobiol 130:1759. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1393-1","journal-title":"Mol Neurobiol"},{"key":"1579_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"1579_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington\u2019s disease. Nat Rev Neurosci 14:708\u2013721. \n                    https:\/\/doi.org\/10.1038\/nrn3570","journal-title":"Nat Rev Neurosci"},{"key":"1579_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","volume":"47C","author":"J Praet","year":"2014","unstructured":"Praet J, Guglielmetti C, Berneman Z, van der Linden A, Ponsaerts P (2014) Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev 47C:485\u2013505. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2014.10.004","journal-title":"Neurosci Biobehav Rev"},{"key":"1579_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jneumeth.2012.06.015","volume":"209","author":"PC Monsma","year":"2012","unstructured":"Monsma PC, Brown A (2012) FluoroMyelin\u2122 red is a bright, photostable and non-toxic fluorescent stain for live imaging of myelin. J Neurosci Methods 209:344\u2013350. \n                    https:\/\/doi.org\/10.1016\/j.jneumeth.2012.06.015","journal-title":"J Neurosci Methods"},{"key":"1579_CR27","doi-asserted-by":"publisher","first-page":"E9685","DOI":"10.1073\/pnas.1714183114","volume":"114","author":"ID Duncan","year":"2017","unstructured":"Duncan ID, Marik RL, Broman AT, Heidari M (2017) Thin myelin sheaths as the hallmark of remyelination persist over time and preserve axon function. PNAS 114:E9685\u2013E9691. \n                    https:\/\/doi.org\/10.1073\/pnas.1714183114","journal-title":"PNAS"},{"key":"1579_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron A, Larochelle A, Laflamme N, Pr\u00e9fontaine P, Plante MM, S\u00e1nchez MG, Yong VW, Stys PK et al (2015) Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med 212:481\u2013495. \n                    https:\/\/doi.org\/10.1084\/jem.20141656","journal-title":"J Exp Med"},{"key":"1579_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/brain\/aws262","volume":"136","author":"T Skripuletz","year":"2013","unstructured":"Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M et al (2013) Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136:147\u2013167. \n                    https:\/\/doi.org\/10.1093\/brain\/aws262","journal-title":"Brain"},{"key":"1579_CR30","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/brain\/awf179","volume":"125","author":"MJ Thieben","year":"2002","unstructured":"Thieben MJ, Duggins AJ, Good CD et al (2002) The distribution of structural neuropathology in pre-clinical Huntington\u2019s disease. Brain 125:1815\u20131828","journal-title":"Brain"},{"key":"1579_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","volume":"140","author":"SAJ Reading","year":"2005","unstructured":"Reading SAJ, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL et al (2005) Regional white matter change in pre-symptomatic Huntington\u2019s disease: a diffusion tensor imaging study. Psychiatry Res 140:55\u201362. \n                    https:\/\/doi.org\/10.1016\/j.pscychresns.2005.05.011","journal-title":"Psychiatry Res"},{"key":"1579_CR32","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med 47:215\u2013222","journal-title":"J Nucl Med"},{"key":"1579_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/mds.20979","volume":"21","author":"HD Rosas","year":"2006","unstructured":"Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH (2006) Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 21:1317\u20131325. \n                    https:\/\/doi.org\/10.1002\/mds.20979","journal-title":"Mov Disord"},{"key":"1579_CR34","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1212\/WNL.0b013e3181d8c20a","volume":"74","author":"D Stoffers","year":"2010","unstructured":"Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR (2010) Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 74:1208\u20131216. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181d8c20a","journal-title":"Neurology"},{"key":"1579_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2019.02.011","volume":"127","author":"CI Radulescu","year":"2019","unstructured":"Radulescu CI, Garcia-Miralles M, Sidik H, Bardile CF, Yusof NABM, Lee HU, Ho EXP, Chu CW et al (2019) Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease. Neurobiol Dis 127:65\u201375. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2019.02.011","journal-title":"Neurobiol Dis"},{"key":"1579_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1023\/A:1025731309829","volume":"31","author":"A Peters","year":"2002","unstructured":"Peters A (2002) The effects of normal aging on myelin and nerve fibers: a review. J Neurocytol 31:581\u2013593","journal-title":"J Neurocytol"},{"key":"1579_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cne.10714","volume":"462","author":"L Marner","year":"2003","unstructured":"Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003) Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 462:144\u2013152. \n                    https:\/\/doi.org\/10.1002\/cne.10714","journal-title":"J Comp Neurol"},{"key":"1579_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","volume":"157","author":"B Kornek","year":"2000","unstructured":"Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M et al (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267\u2013276. \n                    https:\/\/doi.org\/10.1016\/S0002-9440(10)64537-3","journal-title":"Am J Pathol"},{"key":"1579_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","volume":"93","author":"R Dutta","year":"2011","unstructured":"Dutta R, Trapp BD (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93:1\u201312. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2010.09.005","journal-title":"Prog Neurobiol"},{"key":"1579_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11065-009-9113-2","volume":"19","author":"DJ Madden","year":"2009","unstructured":"Madden DJ, Bennett IJ, Song AW (2009) Cerebral white matter integrity and cognitive aging: contributions from diffusion tensor imaging. Neuropsychol Rev 19:415\u2013435. \n                    https:\/\/doi.org\/10.1007\/s11065-009-9113-2","journal-title":"Neuropsychol Rev"},{"key":"1579_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuroscience.2013.11.026","volume":"276","author":"IJ Bennett","year":"2014","unstructured":"Bennett IJ, Madden DJ (2014) Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience 276:187\u2013205. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2013.11.026","journal-title":"Neuroscience"},{"key":"1579_CR42","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1126\/science.1254960","volume":"346","author":"IA McKenzie","year":"2014","unstructured":"McKenzie IA, Ohayon D, Li H et al (2014) Motor skill learning requires active central myelination. Science 346:318\u2013322. \n                    https:\/\/doi.org\/10.1126\/science.1254960","journal-title":"Science"},{"key":"1579_CR43","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nn.4351","volume":"19","author":"L Xiao","year":"2016","unstructured":"Xiao L, Ohayon D, McKenzie IA et al (2016) Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nat Neurosci 19:1210\u20131217. \n                    https:\/\/doi.org\/10.1038\/nn.4351","journal-title":"Nat Neurosci"},{"key":"1579_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nn.4200","volume":"19","author":"K-J Chang","year":"2016","unstructured":"Chang K-J, Redmond SA, Chan JR (2016) Remodeling myelination: implications for mechanisms of neural plasticity. Nat Neurosci 19:190\u2013197. \n                    https:\/\/doi.org\/10.1038\/nn.4200","journal-title":"Nat Neurosci"},{"key":"1579_CR45","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","volume":"85","author":"B Huang","year":"2015","unstructured":"Huang B, Wei W, Wang G, Gaertig MA, Feng Y, Wang W, Li XJ, Li S (2015) Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron 85:1212\u20131226. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2015.02.026","journal-title":"Neuron"},{"key":"1579_CR46","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbalip.2015.02.010","volume":"1851","author":"G Saher","year":"2015","unstructured":"Saher G, Stumpf SK (2015) Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta 1851:1083\u20131094. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2015.02.010","journal-title":"Biochim Biophys Acta"},{"key":"1579_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nn1426","volume":"8","author":"G Saher","year":"2005","unstructured":"Saher G, Br\u00fcgger B, Lappe-Siefke C, M\u00f6bius W, Tozawa RI, Wehr MC, Wieland F, Ishibashi S et al (2005) High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8:468\u2013475. \n                    https:\/\/doi.org\/10.1038\/nn1426","journal-title":"Nat Neurosci"},{"key":"1579_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","volume":"98","author":"M Shankaran","year":"2017","unstructured":"Shankaran M, Di Paolo E, Leoni V et al (2017) Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington\u2019s disease: a cross-validation study in Q175 knock-in mice. Neurobiol Dis 98:66\u201376. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2016.11.013","journal-title":"Neurobiol Dis"},{"key":"1579_CR49","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza M, Marullo M, Di Paolo E et al (2015) Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ 22:690\u2013702. \n                    https:\/\/doi.org\/10.1038\/cdd.2014.162","journal-title":"Cell Death Differ"},{"key":"1579_CR50","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E et al (2010) Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci 30:10844\u201310850. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0917-10.2010","journal-title":"J Neurosci"},{"key":"1579_CR51","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A et al (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci 25:9932\u20139939. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3355-05.2005","journal-title":"J Neurosci"},{"key":"1579_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369. \n                    https:\/\/doi.org\/10.1016\/j.cell.2006.09.015","journal-title":"Cell"},{"key":"1579_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ et al (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2006.10.004","journal-title":"Cell Metab"},{"key":"1579_CR54","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","volume":"34","author":"M Valenza","year":"2011","unstructured":"Valenza M, Cattaneo E (2011) Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci 34:474\u2013486. \n                    https:\/\/doi.org\/10.1016\/j.tins.2011.06.005","journal-title":"Trends Neurosci"},{"key":"1579_CR55","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","volume":"7","author":"M Valenza","year":"2015","unstructured":"Valenza M, Chen JY, Di Paolo E et al (2015) Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice. EMBO Mol Med 7:1547\u20131564. \n                    https:\/\/doi.org\/10.15252\/emmm.201505413","journal-title":"EMBO Mol Med"},{"key":"1579_CR56","doi-asserted-by":"publisher","first-page":"1252304","DOI":"10.1126\/science.1252304","volume":"344","author":"EM Gibson","year":"2014","unstructured":"Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE et al (2014) Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science. 344:1252304. \n                    https:\/\/doi.org\/10.1126\/science.1252304","journal-title":"Science."},{"key":"1579_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2005.03.029","volume":"233","author":"I Coman","year":"2005","unstructured":"Coman I, Barbin G, Charles P, Zalc B, Lubetzki C (2005) Axonal signals in central nervous system myelination, demyelination and remyelination. J Neurol Sci 233:67\u201371. \n                    https:\/\/doi.org\/10.1016\/j.jns.2005.03.029","journal-title":"J Neurol Sci"},{"key":"1579_CR58","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1471-4159.2010.06831.x","volume":"114","author":"G Piaton","year":"2010","unstructured":"Piaton G, Gould RM, Lubetzki C (2010) Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair. J Neurochem 114:1243\u20131260. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06831.x","journal-title":"J Neurochem"},{"key":"1579_CR59","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao J-W, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ et al (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211\u20131218. \n                    https:\/\/doi.org\/10.1038\/nn.3469","journal-title":"Nat Neurosci"},{"key":"1579_CR60","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/brainsci3031109","volume":"3","author":"KI Claycomb","year":"2013","unstructured":"Claycomb KI, Johnson KM, Winokur PN, Sacino A, Crocker S (2013) Astrocyte regulation of CNS inflammation and remyelination. Brain Sci 3:1109\u20131127. \n                    https:\/\/doi.org\/10.3390\/brainsci3031109","journal-title":"Brain Sci"},{"key":"1579_CR61","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","volume":"12","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, You Y-M, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bj\u00f6rkblom B, Coffey ET et al (2009) Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 12:864\u2013871. \n                    https:\/\/doi.org\/10.1038\/nn.2346","journal-title":"Nat Neurosci"},{"key":"1579_CR62","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","volume":"40","author":"BS Khakh","year":"2017","unstructured":"Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R (2017) Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease. Trends Neurosci 40:422\u2013437. \n                    https:\/\/doi.org\/10.1016\/j.tins.2017.05.002","journal-title":"Trends Neurosci"},{"key":"1579_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","volume":"26","author":"R Andre","year":"2015","unstructured":"Andre R, Carty L, Tabrizi SJ (2015) Disruption of immune cell function by mutant huntingtin in Huntington\u2019s disease pathogenesis. Curr Opin Pharmacol 26:33\u201338. \n                    https:\/\/doi.org\/10.1016\/j.coph.2015.09.008","journal-title":"Curr Opin Pharmacol"},{"key":"1579_CR64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517\u2013521. \n                    https:\/\/doi.org\/10.1038\/nature11007","journal-title":"Nature"},{"key":"1579_CR65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443\u2013448. \n                    https:\/\/doi.org\/10.1038\/nature11314","journal-title":"Nature"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1579-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T23:54:42Z","timestamp":1585698882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1579-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}